Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 1
1962 1
1963 3
1964 1
1965 7
1966 2
1967 4
1968 1
1969 1
1970 2
1971 2
1972 1
1973 3
1974 3
1975 2
1976 2
1977 1
1978 5
1979 3
1980 3
1981 6
1982 3
1983 9
1984 3
1985 7
1986 5
1987 1
1988 2
1989 4
1990 8
1991 7
1992 7
1993 6
1994 3
1995 5
1996 4
1997 8
1998 4
1999 5
2000 2
2001 7
2002 8
2003 10
2004 16
2005 11
2006 11
2007 27
2008 26
2009 31
2010 27
2011 17
2012 11
2013 20
2014 26
2015 32
2016 26
2017 21
2018 25
2019 25
2020 41
2021 39
2022 30
2023 41
2024 34
2025 51
2026 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

718 results

Results by year

Filters applied: . Clear all
Page 1
Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice.
Tanaka S, Hikita H, Tatsumi T, Sakamori R, Nozaki Y, Sakane S, Shiode Y, Nakabori T, Saito Y, Hiramatsu N, Tabata K, Kawabata T, Hamasaki M, Eguchi H, Nagano H, Yoshimori T, Takehara T. Tanaka S, et al. Among authors: nozaki y. Hepatology. 2016 Dec;64(6):1994-2014. doi: 10.1002/hep.28820. Epub 2016 Oct 21. Hepatology. 2016. PMID: 27637015
Extrinsic emotion regulation.
Nozaki Y, Mikolajczak M. Nozaki Y, et al. Emotion. 2020 Feb;20(1):10-15. doi: 10.1037/emo0000636. Emotion. 2020. PMID: 31961171 Review.
Comparative effectiveness of subcutaneous sarilumab 200 mg biweekly, subcutaneous Tocilizumab 162 mg biweekly, and intravenous Tocilizumab 8 mg/kg every 4 weeks in patients with rheumatoid arthritis: a prospective cohort study.
Onishi A, Tanaka M, Fujii T, Murata K, Murakami K, Hashimoto M, Watanabe R, Nozaki Y, Ashida C, Yamamoto W, Yamada H, Sendo S, Ebina K, Makino H, Son Y, Wada Y, Hata K, Matsuda S, Morinobu A. Onishi A, et al. Among authors: nozaki y. Arthritis Res Ther. 2025 Mar 7;27(1):52. doi: 10.1186/s13075-025-03514-x. Arthritis Res Ther. 2025. PMID: 40055759 Free PMC article.
Interleukin-18 in Inflammatory Kidney Disease.
Hirooka Y, Nozaki Y. Hirooka Y, et al. Among authors: nozaki y. Front Med (Lausanne). 2021 Mar 1;8:639103. doi: 10.3389/fmed.2021.639103. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33732720 Free PMC article. Review.
Factors involved in gastroesophageal varix-related events in patients with hepatitis C virus-related compensated and decompensated cirrhosis after direct-acting antiviral therapy.
Tahata Y, Hikita H, Mochida S, Enomoto N, Kawada N, Ido A, Miki D, Kurosaki M, Yoshiji H, Sakamori R, Kuroda H, Yatsuhashi H, Yamashita T, Hiasa Y, Kato N, Miyaaki H, Ueno Y, Itoh Y, Matsuura K, Takami T, Asahina Y, Suda G, Akuta N, Tateishi R, Nakamoto Y, Kakazu E, Terai S, Shimizu M, Miyazaki M, Nozaki Y, Sobue S, Yano H, Miyaki T, Moriuchi A, Hori T, Shirai K, Murai K, Saito Y, Kodama T, Tatsumi T, Yamada T, Takehara T. Tahata Y, et al. Among authors: nozaki y. Hepatol Res. 2024 Oct 29. doi: 10.1111/hepr.14131. Online ahead of print. Hepatol Res. 2024. PMID: 39470448
NRF2-COX2-PGE 2 axis drives immune cold tumors and predicts resistance to combination immunotherapy in hepatocellular carcinoma.
Yamamoto S, Kodama T, Kuwano A, Maesaka K, Yoshida-Hashidate T, Shindou H, Takeda H, Shirai K, Myojin Y, Murai K, Makino Y, Tahata Y, Saito Y, Hosui A, Nozaki Y, Nakabori T, Ohkawa K, Tanaka S, Nishio A, Miyazaki M, Hikita H, Motomura K, Lujambio A, Taketomi A, Eguchi H, Takehara T. Yamamoto S, et al. Among authors: nozaki y. Hepatology. 2026 Jan 15. doi: 10.1097/HEP.0000000000001677. Online ahead of print. Hepatology. 2026. PMID: 41538242
Sustained efficacy of second-line JAK inhibitors in patients with rheumatoid arthritis: insights from the ANSWER cohort.
Tsujimoto K, Ebina K, Okamura S, Okita Y, Etani Y, Yamamoto W, Onishi A, Onizawa H, Shirasugi I, Nakano N, Kotani T, Hiramatsu Y, Hashimoto M, Okano T, Nozaki Y, Ashida C, Son Y, Tanaka A, Hara R, Okada S, Kumanogoh A. Tsujimoto K, et al. Among authors: nozaki y. Rheumatology (Oxford). 2025 Jul 1;64(7):4207-4217. doi: 10.1093/rheumatology/keaf157. Rheumatology (Oxford). 2025. PMID: 40111839
The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long-Term Administration of Nucleos(t)ide Analogs.
Murai K, Hikita H, Yamada R, Nishimura Y, Miyazaki M, Ishida H, Hosui A, Sakamori R, Tatsumi N, Ohkawa K, Doi Y, Nawa T, Egawa S, Yoshida Y, Nozaki Y, Imanaka K, Nakahara M, Sakakibara M, Yakushijin T, Ogawa H, Usui T, Matsumoto K, Oze T, Kuriki S, Sometani E, Sung J, Shimoda A, Shigeno S, Maesaka K, Shirai K, Doi A, Tahata Y, Saito Y, Kodama T, Tatsumi T, Yamada T, Takehara T. Murai K, et al. Among authors: nozaki y. Hepatol Res. 2025 Sep;55(9):1228-1238. doi: 10.1111/hepr.14225. Epub 2025 Jun 16. Hepatol Res. 2025. PMID: 40522439
Real-world comparative effectiveness of sarilumab versus Janus kinase inhibitors as monotherapy in rheumatoid arthritis.
Nozaki Y, Kishimoto K, Itami T, Tomita D, Wada Y, Kotani T, Takeuchi T, Hidaka T, Hino S, Miyamoto T, Miyake H, Hatta K, Mamoto K, Yamada Y, Okano T, Okano T, Saegusa J, Horita M, Nishida K, Kinoshita K, Rai S. Nozaki Y, et al. Arthritis Res Ther. 2026 Jan 2;28(1):32. doi: 10.1186/s13075-025-03722-5. Arthritis Res Ther. 2026. PMID: 41484643 Free PMC article.
718 results